Neutrophil extracellular traps induce persistent lung tissue damage via thromboinflammation without altering virus resolution in a mouse coronavirus model

ISTH Academy, Philipp Hohensinner, 409380

Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms

ISTH Academy, Chloé James, 409379

Functional capacity and dyspnea during follow-up after acute pulmonary embolism

ISTH Academy, Stavros Konstantinides, 409378

Patients with moderate hemophilia A and B with a severe bleeding phenotype have an increased burden of disease

ISTH Academy, Saskia Schols, 409377

Antiplatelet period drama: a rush of blood or classic crimson tide?

ISTH Academy, Bethany Samuelson Bannow, 412423

Bad blood: inequity in hemophilia care

ISTH Academy, , 412422

Doing more with less: low-titer group O whole blood resulted in less total transfusions and an independent association with survival in adults with severe traumatic hemorrhage

ISTH Academy, Faculty / Presenters, 409376

Desmopressin to prevent and treat bleeding in pregnant women with an inherited bleeding disorder: a systematic literature review

ISTH Academy, Faculty / Presenters, 409375

Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab

ISTH Academy, Faculty / Presenters, 409374

The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disorders

ISTH Academy, Johanna Gebhart, 409373

Evaluation of collagen turnover biomarkers as an objective measure for efficacy of treatment with rurioctocog alfa pegol in patients with hemophilia A: a secondary analysis of a randomized controlled trial

ISTH Academy, Faculty / Presenters, 409372

Mice possess a more limited natural antihuman factor VIII antibody repertoire than humans that is produced disproportionately by marginal zone B cells

ISTH Academy, David Lillicrap, 409371

COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry

ISTH Academy, Faculty / Presenters, 409370

Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH Subcommittee on Hemostasis and Malignancy

ISTH Academy, , 409369

Timely identification for long-term impairment: a step further for postpulmonary embolism patients

ISTH Academy, , 409368

Evidence-based personalized thromboprophylaxis after major arthroplasty: a new horizon

ISTH Academy, Faculty / Presenters, 409367

Decoding thrombosis through code: a review of computational models

ISTH Academy, David Bark, 409366

Platelet-targeted gene therapy induces immune tolerance in hemophilia and beyond

ISTH Academy, , 409365

Thromboinflammation in acute injury: infections, heatstroke, and trauma

ISTH Academy, Faculty / Presenters, 409364

Tissue factor at the crossroads of coagulation and radiation response in glioblastoma

ISTH Academy, Faculty / Presenters, 409363

Moving

ISTH Academy, Faculty / Presenters, 409362

Issue Information

ISTH Academy, Faculty / Presenters, 409361

Effect of factor XI inhibition on tumor cell-induced coagulation activation

ISTH Academy, Florian Langer, 409381

Antithrombin activity and central venous catheter-associated thrombosis in critically ill children at high risk of bleeding

ISTH Academy, E. Vincent Faustino, 409382

High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation

ISTH Academy, David Gailani, 409383

Development and validation of a clinical prediction model for 90-day venous thromboembolism risk following total hip and total knee arthroplasty: a multinational study

ISTH Academy, , 409384

PI3KC2α inhibition is antithrombotic in blood from hypercholesterolemic mice

ISTH Academy, Justin Hamilton, 409385

Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis Day

ISTH Academy, Stefano Barco, 409386

Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model

ISTH Academy, Paul Kim, 409387

Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2, and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand

ISTH Academy, Steve Watson, 409388

COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines/SGLT2 prooxidant pathway

ISTH Academy, , 409389

Reversal of factor XI targeting anticoagulants: an in vitro evaluation

ISTH Academy, Joost Meijers, 409390

Evaluation of laboratory testing parameters for vaccine-induced immune thrombotic thrombocytopenia and their implications for diagnosis

ISTH Academy, Ishac Nazy, 409391

ISTH News and Updates: Join the ISTH Today

ISTH Academy, Faculty / Presenters, 409392

Issue Information

ISTH Academy, Faculty / Presenters, 412419

Hello and goodbye Research and Practice in Thrombosis and Haemostasis

ISTH Academy, , 412420

Deep vein thrombosis testing in pregnancy: where is the evidence? Commentary on “Use of single whole-leg ultrasound to exclude suspected deep vein thrombosis in pregnant patients”

ISTH Academy, Kerstin de Wit, 412421

New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry

ISTH Academy, , 408150

PACSIN2 regulates platelet integrin β1 hemostatic function

ISTH Academy, Herve Falet, 408151

A regulatory node involving Gα, PLCβ, and RGS proteins modulates platelet reactivity to critical agonists

ISTH Academy, Peisong Ma, 408152

Thrombin receptor PAR1 silencing in endothelial colony–forming cells modifies stemness and vasculogenic properties

ISTH Academy, Faculty / Presenters, 408153

Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis

ISTH Academy, Faculty / Presenters, 408154

Corrigendum to ‘Evaluation of Venous Thromboembolism Risk Factors Reveals Subtype Heterogenicity in Children with Central Venous Catheters: A Multi-Center Study from the CHAT Consortium’ [Journal of Thrombosis and Haemostasis 21/9 (2023) 2441 - 2450]

ISTH Academy, Faculty / Presenters, 408155

ISTH News and Updates: Join the ISTH Today

ISTH Academy, Faculty / Presenters, 408156

SINE-VNTR-Alu retrotransposon insertion as a novel mutational event underlying Glanzmann thrombasthenia

ISTH Academy, , 408149

Fibrinogenolysis and fibrinolysis in vaccine-induced immune thrombocytopenia and thrombosis

ISTH Academy, Nicola Mutch, 408148

Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry

ISTH Academy, James Douketis, 408147

The TFPIα C-terminal tail is essential for TFPIα-FV-short-protein S complex formation and synergistic enhancement of TFPIα

ISTH Academy, Josefin Ahnstrom, 408146

Design and characterization of novel activated protein C variants for the proteolysis of cytotoxic extracellular histone H3

ISTH Academy, Gerry Nicolaes, 408145

Projected impact of guidelines on incidence of venous thromboembolism after cesarean delivery in the United States

ISTH Academy, Faculty / Presenters, 408144

Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay

ISTH Academy, Faculty / Presenters, 408143

Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion

ISTH Academy, Prosenjit Sen, 408142

Structural analyses of β-glycoprotein I: is there a circular conformation?

ISTH Academy, Nicola Pozzi, 408141

Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfa

ISTH Academy, Sol Schulman, 408140

Postmortem diagnosis of severe factor X deficiency in a fetus with intracranial hemorrhage resulting in intrauterine death

ISTH Academy, Faculty / Presenters, 408139

Functional determination of emicizumab in presence of factor VIII activity

ISTH Academy, Jens Müller, 408138

Coagulation factor VIII regulates von Willebrand factor homeostasis in vivo

ISTH Academy, X. Long Zheng, 408137

Postpartum hemorrhage in Sub-Saharan Africa—a prospective study in metropolitan Mozambique

ISTH Academy, Faculty / Presenters, 408136

Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1

ISTH Academy, Faculty / Presenters, 408135

Pharmacokinetic-guided versus standard prophylaxis in hemophilia: a systematic review and meta-analysis

ISTH Academy, Ingrid Pabinger, 408134

Factor VIIa releases phosphatidylserine-enriched extracellular vesicles from endothelial cells by activating acid sphingomyelinase

ISTH Academy, Vijay Rao, 408133

Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpura

ISTH Academy, Jan Voorberg, 408132

Cattle-FRETS71, a novel fluorogenic substrate with broad applicability for characterizing ADAMTS13 properties and function

ISTH Academy, Joshua Muia, 408131

Acquired von Willebrand disease in children undergoing extracorporeal membrane oxygenation: a prospective observational study

ISTH Academy, Heleen Van Ommen, 408130

Dynamic and functional linkage between von Willebrand factor and ADAMTS-13 with aging: an Atherosclerosis Risk in Community study

ISTH Academy, Jing-Fei Dong, 408129

Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation

ISTH Academy, , 408128

von Willebrand factor: aging is better?

ISTH Academy, Faculty / Presenters, 408127

Commentary on “Structural analyses of β2-glycoprotein I: is there a circular conformation?”

ISTH Academy, Raimondo De Cristofaro, 408126

Unraveling coagulation factor–mediated cellular signaling

ISTH Academy, Roger Preston, 408125

Cellular stress and coagulation factor production: when more is not necessarily better

ISTH Academy, , 408124

Antiplatelet strategies: past, present, and future

ISTH Academy, Michael Holinstat, 408123

The fibrinolysis renaissance

ISTH Academy, Faculty / Presenters, 408122

Genomic science of risk prediction for venous thromboembolic disease: convenient clarification or compounding complexity

ISTH Academy, Frits Rosendaal, 408121

Crippling down factor IX for therapeutic gain

ISTH Academy, Mettine Bos, 408120

Looking Back—And Forward

ISTH Academy, Faculty / Presenters, 408119

COVID-19 and Thrombosis: An Update

ISTH Academy, Faculty / Presenters, 403913

Short - COVID-19 and Thrombosis: An Update

ISTH Academy, Faculty / Presenters, 408158

SSC on the Case: Pediatric and Neonatal Thrombosis and Hemostasis

ISTH Academy, Faculty / Presenters, 405877

From Guidance to Practice: Management of Chemotherapy Induced Thrombocytopenia

ISTH Academy, Gerald Soff, 405878

Posttraumatic stress disorder and posttraumatic stress symptoms among adults with hemophilia A and B

ISTH Academy, Faculty / Presenters, 409278

Venous thromboembolism among physically active young adult females

ISTH Academy, Anna Gurevich-Shapiro, 409277

D-dimer predicts venous thromboembolism in multiple myeloma: a nested case-control study

ISTH Academy, Faculty / Presenters, 409276

What can historical literature on von Willebrand disease teach us?

ISTH Academy, Faculty / Presenters, 409275

Immune cell–mediated venous thrombus resolution

ISTH Academy, Faculty / Presenters, 409274

Investigating patients for bleeding disorders when most of the “usual” ones have been ruled out

ISTH Academy, Johanna Gebhart, 409273

Use of direct oral anticoagulants for venous thromboembolism treatment at extremes of body weight, renal and liver function: an illustrated review

ISTH Academy, , 409272

The crux of menopausal hormone therapy: dose, route, and age

ISTH Academy, Lisa Baumann Kreuziger, 409271

TMEM16E: unscrambling our knowledge about coagulation

ISTH Academy, Rinku Majumder, 405622

Treatment of chemotherapy-induced thrombocytopenia with monotherapy versus combination therapy: the devil is in the details

ISTH Academy, Hanny Al-Samkari, 409269

A need to refine venous thromboembolism risk assessment: the challenge of optimizing patient selection for thromboprophylaxis among hospitalized adults

ISTH Academy, , 409268

Heparin-induced thrombocytopenia (and autoimmune heparin-induced thrombocytopenia): an illustrious review

ISTH Academy, Theodore (Ted) Warkentin, 409267

How We Write a Manuscript Discussion

ISTH Academy, Mary Cushman, 409266

Sex Matters: Policy on Reporting Sex as a Biological Variable at Research and Practice in Thrombosis and Hemostasis

ISTH Academy, , 409265

Issue Information

ISTH Academy, Faculty / Presenters, 409264

APC-PAR1-R46 signaling limits CXCL1 expression during poly IC-induced airway inflammation in mice

ISTH Academy, Silvio Antoniak, 405652

MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylation

ISTH Academy, Frédéric Adam, 405651

Characterization of all small RNAs in and comparisons across cultured megakaryocytes and platelets of healthy individuals and COVID-19 patients

ISTH Academy, , 405650

Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy

ISTH Academy, , 405649

Branched-chain amino acids promote thrombocytopoiesis by activating mTOR signaling

ISTH Academy, Yanyan Xu, 405648

Heavy menstrual bleeding in adolescents: a primary issue in primary care

ISTH Academy, Angela Weyand, 409270